Trontinemab's Phase Ib/IIa Brainshuttle AD study continues to show rapid and robust clearance of amyloid plaques, with 91% becoming amyloid PET negative and ARIA-E remaining Design of the Phase III TR ...

Trontinemab’s Phase Ib/IIa Brainshuttle™ AD study continues to show rapid and robust clearance of amyloid plaques, with 91% ...

Medically the symptoms are known as myalgic encephalomyelitis or chronic fatigue syndrome (ME/CFS). The World Health ...

Some of the experimental treatments require maintenance in the form of surgery and additional follow-up care, leaving many ...

Abivax dazzled investors and analysts with positive data from a pair of Phase III induction trials assessing obefazimod in adults with moderately to severely active ulcerative colitis. The results ...

These two Food and Drug Administration-approved drugs for cancer treatment may hold the key to reversing Alzheimer's disease ...

A new study from the University of British Columbia (UBC) has found that high insulin levels—commonly seen in people with ...

Experts are calling for tailored strategies to enhance the diagnosis, treatment, and monitoring of older people with multiple ...

There is an urgent need for more inclusive and community-focused cancer clinical trials, according to Kimberly (Cary) ...

Raleigh-based Focal Medical, an oncology device company that received early funding from the North Carolina Biotechnology Center, has been acquired by a Florida biopharmaceutical company. Financial ...

Unpredictable FDA and funding woes delay crucial drug approvals, depriving thousands of patients access to vital treatments ...

The trial will test several treatment approaches in the maintenance setting for extensive stage small cell lung cancer.